DNA DRUG REPORTS

The Drug DNA report is for chronic care, including diabetic, cancer and  heart disease patients on multiple medications. The report analyzes  patient-specific DNA data and how that person is likely to respond to medications. Patient genotypes are mapped to maximize drug therapy  efficacy, minimize potential drug interactions and enhance outcomes.

High-risk medications have the potential to cause significant patient  harm or even death when used erroneously. Special safeguards should be  in place in most healthcare institutions to minimize the risk of errors  associated with these medications.

Particularly high-risk medications include:

• Epinephrine
• Vasopressin
• Epoprostenol
• Insulin
• Heparin
• Magnesium sulfate
• Nitroprusside sodium
• Potassium chloride
• Potassium phosphates
• Promethazine
• Benzodiazepines
• Opiates
• Medications administered by anesthesiology

FSA & HSA are accepted as long as they have a major credit logo. Typically, either VISA or MasterCard.

* The DNA Drug Report will be reviewed and summarized by our RPH as long as the submission form is submitted with your order.